Previously, plasma levels of phosphorylated tau [153], amyloid-β (1-40/1-42) [154,155,156,157,158,159], and α-synuclein [121] have been studied for their potential to predict or diagnose AD and PD. This evidence concerns the gene MAPT and Alzheimer disease.